{
    "2018-07-12": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Pharma Stocks Goldman Sachs Sees as Buys",
                "features": {
                    "keywords": [
                        "Pharma",
                        "Goldman Sachs",
                        "Buys"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-04-10",
                "original_text": "AbbVie's Imbruvica Fails in Phase III Blood Cancer Study",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Imbruvica",
                        "Phase III",
                        "Blood Cancer",
                        "Fails"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-05-02",
                "original_text": "Keep Your Eyes on Healthcare's Odd Couple: AbbVie and Alphabet",
                "features": {
                    "keywords": [
                        "Healthcare",
                        "AbbVie",
                        "Alphabet"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "technology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-06-15",
                "original_text": "J&J (JNJ) to Set Pharma Q2 Earnings in Motion: What's Up?",
                "features": {
                    "keywords": [
                        "J&J",
                        "Pharma",
                        "Q2",
                        "Earnings"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-20",
                "original_text": "Benzinga's Daily Biotech Pulse: AbbVie Files sNDA For Leukemia Drug, AcelRx Offering, Aurinia Starts Mid-Stage Trial",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "sNDA",
                        "Leukemia",
                        "Drug",
                        "AcelRx",
                        "Aurinia",
                        "Trial"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-10",
                "original_text": "AbbVie Gives Disappointing Update on Imbruvica Study",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Imbruvica",
                        "Disappointing",
                        "Update",
                        "Study"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-09-15",
                "original_text": "The drug pricing playbook: how pharma companies keep costs high",
                "features": {
                    "keywords": [
                        "drug pricing",
                        "pharma",
                        "costs",
                        "high"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-10-25",
                "original_text": "AbbVie Announces Submission of Supplemental New Drug Application to US FDA for Venetoclax in Newly Diagnosed Acute Myeloid Leukemia Patients Ineligible for Intensive Chemotherapy",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Venetoclax",
                        "FDA",
                        "Acute Myeloid Leukemia",
                        "Submission"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-10",
                "original_text": "Genentech Announces Submission Of SNDA For Venclexta - Quick Facts",
                "features": {
                    "keywords": [
                        "Genentech",
                        "SNDA",
                        "Venclexta"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}